Intravenous thrombolysis for bioprosthetic valve thrombosis

Eur Heart J. 2023 Aug 22;44(32):3104. doi: 10.1093/eurheartj/ehad303.
No abstract available

MeSH terms

  • Anticoagulants / therapeutic use
  • Bioprosthesis* / adverse effects
  • Heart Valve Prosthesis* / adverse effects
  • Humans
  • Prosthesis Failure
  • Thrombolytic Therapy
  • Thrombosis* / drug therapy

Substances

  • Anticoagulants